May 15, 2017 / 12:52 PM / in 2 months

BRIEF-Galectin Therapeutics Q1 loss per share $0.15

1 Min Read

May 15 (Reuters) - Galectin Therapeutics Inc

* Galectin therapeutics reports 2017 first quarter financial results and provides business update

* Q1 loss per share $0.15

* As of march 31, 2017, company had $13.6 million of non-restricted cash and cash equivalents Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below